Works by Mäkelä, Mika

Results: 109
    1

    Study protocol for a randomized double-blinded placebo-controlled trial on ASA therapy for patients with chronic rhinosinusitis with nasal polyps, NSAID-exacerbated respiratory disease, and asthma.

    Published in:
    Frontiers in Allergy, 2025, p. 1, doi. 10.3389/falgy.2025.1542481
    By:
    • Toppila-Salmi, Sanna;
    • Lyly, Annina;
    • Salmi, Viljami;
    • Nuutinen, Mikko;
    • Kilpiö, Michael;
    • Hanif, Tanzeela;
    • Niemi, Mikko;
    • Laulajainen-Hongisto, Anu;
    • Hafrén, Lena;
    • Mäkelä, Mika;
    • Kauppi, Paula;
    • Virkkula, Paula;
    • Helevä, Alma
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Helsinki alert of biodiversity and health.

    Published in:
    Annals of Medicine, 2015, v. 47, n. 3, p. 218, doi. 10.3109/07853890.2015.1010226
    By:
    • von Hertzen, Leena;
    • Beutler, Bruce;
    • Bienenstock, John;
    • Blaser, Martin;
    • Cani, Patrice D.;
    • Eriksson, Johan;
    • Färkkilä, Martti;
    • Haahtela, Tari;
    • Hanski, Ilkka;
    • Jenmalm, Maria C.;
    • Kere, Juha;
    • Knip, Mikael;
    • Kontula, Kimmo;
    • Koskenvuo, Markku;
    • Ling, Charlotte;
    • Mandrup-Poulsen, Thomas;
    • von Mutius, Erika;
    • Mäkelä, Mika J.;
    • Paunio, Tiina;
    • Pershagen, Göran
    Publication type:
    Article
    32
    33
    34

    Study protocol for a randomized double-blinded placebo-controlled trial on mepolizumab for patients with chronic rhinosinusitis with nasal polyps, NSAID exacerbated respiratory disease and asthma.

    Published in:
    Frontiers in Allergy, 2025, p. 1, doi. 10.3389/falgy.2025.1568081
    By:
    • Lyly, Annina;
    • Sahlman, Johanna;
    • Pajala, Karoliina;
    • Salminen, Maija;
    • Sillanpää, Saara;
    • Numminen, Jura;
    • Hanif, Tanzeela;
    • Laulajainen-Hongisto, Anu;
    • Mäkelä, Mika;
    • Kauppi, Paula;
    • Kangasniemi, Iiris;
    • Lilja, Markus;
    • Hammaren-Malmi, Sari;
    • Virkkula, Paula;
    • Toppila-Salmi, Sanna
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    EAACI Biologicals Guidelines—Recommendations for severe asthma.

    Published in:
    Allergy, 2021, v. 76, n. 1, p. 14, doi. 10.1111/all.14425
    By:
    • Agache, Ioana;
    • Akdis, Cezmi A.;
    • Akdis, Mubeccel;
    • Canonica, Giorgio Walter;
    • Casale, Thomas;
    • Chivato, Tomas;
    • Corren, Jonathan;
    • Chu, Derek K.;
    • Del Giacco, Stefano;
    • Eiwegger, Thomas;
    • Flood, Breda;
    • Firinu, Davide;
    • Gern, James E.;
    • Hamelmann, Eckard;
    • Hanania, Nicola;
    • Hernández‐Martín, Irene;
    • Knibb, Rebeca;
    • Mäkelä, Mika;
    • Nair, Parameswaran;
    • O'Mahony, Liam
    Publication type:
    Article
    46
    47
    48

    Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma.

    Published in:
    Allergy, 2020, v. 75, n. 5, p. 1058, doi. 10.1111/all.14268
    By:
    • Agache, Ioana;
    • Song, Yang;
    • Rocha, Claudio;
    • Beltran, Jessica;
    • Posso, Margarita;
    • Steiner, Corinna;
    • Alonso‐Coello, Pablo;
    • Akdis, Cezmi;
    • Akdis, Mubeccel;
    • Canonica, Giorgio Walter;
    • Casale, Thomas;
    • Chivato, Tomas;
    • Corren, Jonathan;
    • Giacco, Stefano;
    • Eiwegger, Thomas;
    • Firinu, Davide;
    • Gern, James E.;
    • Hamelmann, Eckard;
    • Hanania, Nicola;
    • Mäkelä, Mika
    Publication type:
    Article
    49

    Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma.

    Published in:
    Allergy, 2020, v. 75, n. 5, p. 1043, doi. 10.1111/all.14235
    By:
    • Agache, Ioana;
    • Rocha, Claudio;
    • Beltran, Jessica;
    • Song, Yang;
    • Posso, Margarita;
    • Solà, Ivan;
    • Alonso‐Coello, Pablo;
    • Akdis, Cezmi;
    • Akdis, Mubeccel;
    • Canonica, Giorgio W.;
    • Casale, Thomas;
    • Chivato, Tomas;
    • Corren, Jonathan;
    • Del Giacco, Stefano;
    • Eiwegger, Thomas;
    • Firinu, Davide;
    • Gern, James E.;
    • Hamelmann, Eckard;
    • Hanania, Nicola;
    • Mäkelä, Mika
    Publication type:
    Article
    50

    Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma

    Published in:
    Allergy, 2020, v. 75, n. 5, p. 1023, doi. 10.1111/all.14221
    By:
    • Agache, Ioana;
    • Beltran, Jessica;
    • Akdis, Cezmi;
    • Akdis, Mubeccel;
    • Canelo‐Aybar, Carlos;
    • Canonica, Giorgio Walter;
    • Casale, Thomas;
    • Chivato, Tomas;
    • Corren, Jonathan;
    • Del Giacco, Stefano;
    • Eiwegger, Thomas;
    • Firinu, Davide;
    • Gern, James E.;
    • Hamelmann, Eckard;
    • Hanania, Nicola;
    • Mäkelä, Mika;
    • Hernández‐Martín, Irene;
    • Nair, Parameswaran;
    • O'Mahony, Liam;
    • Papadopoulos, Nikolaos G.
    Publication type:
    Article